PTAB Podcast: Recent USPTO Update on Fintiv Factors and Discretionary Denials

Choate's Life Sciences Insights

English - July 11, 2022 04:00 - 18 minutes - 1.08 KB - ★★★★★ - 1 rating
Technology Government life sciences patent intellectual property clinical trials patent ip trial litigation corporate law Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Conducting Clinical Trials Part 5: Confidentiality Issues

Next Episode: A Debrief of the Supreme Court’s Decision in Amgen v. Sanofi

Steph Schonewald, Sophie Wang and Emily Miller discuss the recent memo issued by USPTO Director Vidal concerning the Fintiv factors and discretionary denials in AIA post-grant proceedings.